Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Unraveling genetic threads: Identifying novel therapeutic targets for allergic rhinitis through Mendelian randomization

Submitted by Frida Mäkelä on Wed, 08/07/2024 - 11:32
  • Read more about Unraveling genetic threads: Identifying novel therapeutic targets for allergic rhinitis through Mendelian randomization

Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine

Submitted by Frida Mäkelä on Wed, 08/07/2024 - 11:29
  • Read more about Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine

Identifying novel potential drug targets for endometriosis via plasma proteome screening

Submitted by Frida Mäkelä on Wed, 08/07/2024 - 10:28
  • Read more about Identifying novel potential drug targets for endometriosis via plasma proteome screening

PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses

Submitted by Frida Mäkelä on Wed, 08/07/2024 - 10:01
  • Read more about PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses

Occlusion dysfunction and Alzheimer's disease: Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 08/06/2024 - 17:10
  • Read more about Occlusion dysfunction and Alzheimer's disease: Mendelian randomization study

Association between genetically proxied PPARG activation and psoriasis vulgaris: a Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 08/06/2024 - 17:02
  • Read more about Association between genetically proxied PPARG activation and psoriasis vulgaris: a Mendelian randomization study

Circulating inflammatory proteins and abdominal aortic aneurysm: A two-sample Mendelian randomization and colocalization analyses

Submitted by Frida Mäkelä on Tue, 08/06/2024 - 16:52
  • Read more about Circulating inflammatory proteins and abdominal aortic aneurysm: A two-sample Mendelian randomization and colocalization analyses

Integrating genetic and proteomic data to elucidate the association between immune system and blood-brain barrier dysfunction with multiple sclerosis risk and severity

Submitted by Frida Mäkelä on Tue, 08/06/2024 - 16:47
  • Read more about Integrating genetic and proteomic data to elucidate the association between immune system and blood-brain barrier dysfunction with multiple sclerosis risk and severity

Navigating the gut-bone axis: The pivotal role of Coprococcus3 in osteoporosis prevention through Mendelian randomization

Submitted by Frida Mäkelä on Tue, 08/06/2024 - 16:34
  • Read more about Navigating the gut-bone axis: The pivotal role of Coprococcus3 in osteoporosis prevention through Mendelian randomization

Causal relationship between gut microbiota and idiopathic pulmonary fibrosis: A two-sample Mendelian randomization

Submitted by Frida Mäkelä on Tue, 08/06/2024 - 16:24
  • Read more about Causal relationship between gut microbiota and idiopathic pulmonary fibrosis: A two-sample Mendelian randomization

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 252
  • Page 253
  • Page 254
  • Page 255
  • Current page 256
  • Page 257
  • Page 258
  • Page 259
  • Page 260
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement